☰

EBD Group and Current Partnering Form Strategic Collaboration


    EBD Group, the leading partnering firm for the global life sciences, and Current Partnering, a publisher of life science intelligence for dealmakers and the only provider of biopharma dealmaking reports globally, today announced a strategic collaboration to incorporate Current Partnering´s dealmaking-focused content into EBD Group´s virtual partnering platform, partnering360®. Users of partnering360 will now be able to access a range of information from Current Partnering covering all aspects of partnering best practices and deal terms, such as deal-focused reports and insightful articles designed to optimize partnering strategy and dealmaking tactics.

    "We are pleased to be able to provide Current Partnering´s high quality and partnering-focused content to members of partnering360," said Florian Schoenhammer, Managing Director, EBD Group. "This collaboration is part of our continuing effort to enrich partnering360 with data and information from leading sources to help our users make better partnering decisions."

    "We are excited to bring Current Partnering´s unique life science content to partnering360, the largest virtual partnering platform in the life science industry. partnering360 members can now benefit from Current Partnering business intelligence derived from thousands of individual deal, alliance and M&A records to craft better deals," said Steve Poile, Chief Executive Officer, Current Partnering.

    partnering360 is the largest virtual partnering network in the life science industry. partnering360 is a key part of EBD Group´s comprehensive partnering solution consisting of conferences, software and services that together form the backbone of a highly-productive and efficient partnering process for life science companies around the world.

    Current Partnering provides ready and affordable access to business intelligence information across the life sciences, allowing companies to better prepare for negotiations and understand the potential deal structures available to them. Providing both dealmaking reports and a deals database, Current Partnering assists life science professionals to benchmark deals, track competitors and to understand deal terms.

    EBD Group produces seven of its own landmark partnering events attracting 10,000 senior life science executives and generating more than 44,000 one-to-one partnering meetings every year. Event-based partnering activity data is seamlessly integrated with partnering360, enabling users to continue their partner engagement virtually, while opening new streams of collaboration with over 24,000 dealmakers, innovators, investors, academics and service providers.

    About EBD Group

    EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

    EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

    • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
    • BioPharm America™, the fastest growing partnering event in North America
    • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
    • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
    • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
    • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
    • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

    EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

    EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

    EBD Group has offices in the USA and Europe.

    For more information please visit www.ebdgroup.com.

    About Current Partnering

    Current Partnering – Life science intelligence for dealmakers - is the leading publisher of partnering deal term reports within the life sciences. Designed to translate research into commercial success, Current Partnering disseminates the latest partnering activity trends across the life sciences.

    Current Partnering report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities.

    Current Partnering also offers Current Agreements, the leading deals and alliances database for the life sciences sector.

    Dating back to 2000, Current Agreements provides comprehensive coverage of life science:

    • Partnerships
    • M&A
    • Financings

    Current Agreements allows you to discover actual contract terms between alliance partners and benchmark partnering payment deal terms. Current Agreements is updated daily by our in-house team of deal experts, with over 100 new deals added every week. Current Agreements currently tracks over 40,000 partnering deals, M&A and financings.

    Current Partnering is based in the UK.

    For more information please visit www.currentpartnering.com

     

    Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140602005136/en/